No abstract available
Keywords:
Daratumumab; multiple myeloma; subcutaneous administration.
MeSH terms
-
Antibodies, Monoclonal* / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols
-
Humans
-
Multiple Myeloma* / drug therapy
Substances
-
Antibodies, Monoclonal
-
daratumumab